GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Short Interest

IDEXX Laboratories (BSP:I1DX34) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of IDEXX Laboratories's Short Interest

For the Diagnostics & Research subindustry, IDEXX Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Short Interest falls into.



IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines